AKT1 and hepatocellular carcinoma: Moreover, it was reported that PI3K/AKT/mTOR signaling pathway is strongly related to HCC development and the inhibition of PI3K signaling axis could be a HCC treatment strategy (Dimri and Satyanarayana, 2020).